Indications and Usage for Sildenafil Tablets. Adults. Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO]
Indications and Usage for Sildenafil Oral Suspension. Adults. Sildenafil for oral suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World
Sildenafil (Revatio ) Indications: Sildenafil is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening. The efficacy of sildenafil has not
TruPharma LLC: Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets are phosphodiesterase-5 (PDE5) inhibitor indicated for the
Women: Sildenafil is not indicated in pregnant women. Pediatrics: Sildenafil is not indicated in children. Pregnancy: There are no adequate and well controlled studies of Sildenafil in pregnant women. Sildenafil is not indicated in pregnant women. Lactation: Sildenafil is not indicated in nursing mothers. ADVERSE EFFECTS
Sildenafil is used for the treatment of digital ulcer, E but is not licensed for this indication. Contra-indications Contra-indications For sildenafil. General contra-indications:
CIPLA USA INC,: Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile
SILDENAFIL CITRATE. What is the Trade Name for SILDENAFIL CITRATE? Sildenafil for Oral Suspension. What are the Indications for SILDENAFIL CITRATE? 1 INDICATIONS AND USAGE Sildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in adults to improve exercise ability and delay clinical worsening.
What is the generic name? SILDENAFIL. What is the Trade Name for SILDENAFIL? Sildenafil Citrate. What are the Indications for SILDENAFIL? 1. INDICATIONS AND USAGE Sildenafil tablets are phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical
Comments
Great story though....